Bioventix

1. 24 Jun 26
   Director/PDMR Shareholding Director buys

   Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces the Company was notified that earlier today Bruce Hiscock, Chief Financial...

   RNS 9635132 ↗
2. 18 May 26
   Holding(s) in Company

   RNS 9572970 ↗
3. 28 Apr 26
   Director/PDMR Shareholding Director buys

   Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company was notified today that on 27 April 2026 Bruce Hiscock,...

   RNS 9542485 ↗
4. 20 Apr 26
   Share Options Awarded

   Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces the award on 17 April 2026 of share options over ordinary shares in the...

   RNS 9528527 ↗
5. 13 Apr 26
   Director/PDMR Shareholding Director buysRepeated director buys

   Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company was notified on 10 April 2026 that Ian Nicholson,...

   RNS 9515725 ↗
6. 08 Apr 26
   Director/PDMR Shareholding Director buys

   Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company has been notified that earlier today Peter Harrison, Chief...

   RNS 9511051 ↗
7. 02 Apr 26
   Director/PDMR Shareholding Director buys

   Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company was notified on 2 April 2026 that on 2 April 2026 Bruce...

   RNS 9506151 ↗
8. 02 Apr 26
   Holding(s) in Company

   RNS 9505554 ↗
9. 30 Mar 26
   Half-year Results

   Unaudited Interim Results for the six months ended 31 December 2025

   RNS 9496897 ↗
10. 24 Feb 26
    Appointment of Non-Executive Director

    Bioventix PLC (AIM: BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, is delighted to announce the appointment of Chris Yates as independent...

    RNS 9443376 ↗
11. 04 Dec 25
    Result of AGM

    RNS 9276823 ↗
12. 26 Nov 25
    Director/PDMR Shareholding Director buys

    Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company was notified yesterday that on 25 November 2025, Bruce...

    RNS 9258324 ↗
13. 18 Nov 25
    Holding(s) in Company

    RNS 9241198 ↗
14. 11 Nov 25
    Posting of Annual Report and Notice of AGM

    RNS 9225028 ↗
15. 04 Nov 25
    Director/PDMR Shareholding Director buysRepeated director buys

    Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company has been notified that earlier today Peter Harrison, Chief...

    RNS 9212210 ↗
16. 30 Oct 25
    Director/PDMR Shareholding Director buys

    Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company was notified on 29 October 2025 that Ian Nicholson,...

    RNS 9202827 ↗
17. 27 Oct 25
    Director/PDMR Shareholding Director buys

    Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company was notified that earlier today Bruce Hiscock, Chief...

    RNS 9197116 ↗
18. 27 Oct 25
    Results for the year ended 30 June 2025

    Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces its audited results for the year ended 30 June 2025.

    RNS 9195153 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.